Király József, Szabó Erzsébet, Fodor Petra, Vass Anna, Choudhury Mahua, Gesztelyi Rudolf, Szász Csaba, Flaskó Tibor, Dobos Nikoletta, Zsebik Barbara, Steli Ákos József, Halmos Gábor, Szabó Zsuzsanna
Department of Biopharmacy, Faculty of Pharmacy, University of Debrecen, 4032 Debrecen, Hungary.
Doctoral School of Pharmaceutical Sciences, University of Debrecen, 4032 Debrecen, Hungary.
Biomedicines. 2024 Jun 27;12(7):1441. doi: 10.3390/biomedicines12071441.
BACKGROUND: MicroRNAs (miRNAs) play a regulatory role in various human cancers. The roles of hsa-miR-15a-5p, hsa-miR-99b-5p, and hsa-miR-181a-5p have not been fully explored in the angiogenesis of renal cell carcinoma (RCC). AIMS: The present study aimed to evaluate the expression of these miRNAs in tumorous and adjacent healthy tissues of RCC. METHODS: Paired tumorous and adjacent normal kidney tissues from 20 patients were studied. The expression levels of hsa-miR-15b-5p, hsa-miR-99b-5p, and hsa-miR-181a-5p were quantified by TaqMan miRNA Assays. Putative targets were analyzed by qRT-PCR. RESULTS: Significant downregulation of all three miRNAs investigated was observed in tumorous samples compared to adjacent normal kidney tissues. Spearman analysis showed a negative correlation between the expression levels of miRNAs and the pathological grades of the patients. Increased expression of vascular endothelial growth factor-A (VEGF-A) and hypoxia-inducible factor-1α (HIF-1α), a tissue inhibitor of metalloproteinases-1 (TIMP-1), was observed in tumorous samples compared to adjacent normal tissues. Depletion of tissue inhibitors of metalloproteinase-2 (TIMP-2) and metalloproteinase-2 (MMP-2) was detected compared to normal adjacent tissues. The examined miRNAs might function as contributing factors to renal carcinogenesis. However, more prospective studies are warranted to evaluate the potential role of miRNAs in RCC angiogenesis.
BMC Endocr Disord. 2023-10-30
Mol Hum Reprod. 2017-1
J Headache Pain. 2024-5-16
Expert Opin Ther Targets. 2024-12
Int J Mol Sci. 2023-6-29
Cancers (Basel). 2022-12-14
Technol Cancer Res Treat. 2022
Signal Transduct Target Ther. 2022-1-19
J Assist Reprod Genet. 2022-2
Med Sci Monit. 2021-5-8
Cancer Cell Int. 2021-4-17